Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03251963 · ClinicalTrials.gov registry record · Phase 2
Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients
A Phase 2 study, sponsored by University of Utah.
- Completed
- Registry status
- Phase 2
- Development phase
- 131
- Enrollment target
NCT03251963: Completed Phase 2 study, sponsored by University of Utah.
NCT03251963 is a Phase 2 study that has completed, run by University of Utah. The registered enrollment target is 131 participants, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03251963, a Phase 2 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 131 participants
- Enrollment target
Study Summary
The aim of this research is to better understand how patient-level factors can be used to predict the appropriate enoxaparin dose to maximize venous thromboembolism (VTE) risk reduction and minimize bleeding.
Primary Outcome
Number of patients with in range initial peak Xa level
Interventions
- DRUG Fixed Dose Enoxaparin
- DRUG Variable Dose Enoxaparin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2017-09-15 |
| Est. Completion | 2019-07-27 |
| Phase | Phase 2 |
What the finished NCT03251963 record still lists
NCT03251963 is an interventional study that assigns participants to a tested intervention. The registered 131 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Fixed Dose Enoxaparin is the first listed.
NCT03251963 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03251963 about?
NCT03251963 is a clinical study titled "Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients". The aim of this research is to better understand how patient-level factors can be used to predict the appropriate enoxaparin dose to maximize venous thromboembolism (VTE) risk reduction and minimize bleeding.
What is the current status of trial NCT03251963?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 131 participants. The study started on 2017-09-15. Estimated completion is 2019-07-27.
What interventions are being tested in trial NCT03251963?
The interventions under investigation include: Fixed Dose Enoxaparin (DRUG), Variable Dose Enoxaparin (DRUG).
Who is sponsoring clinical trial NCT03251963?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03251963's enrollment target sits among peer trials
131 541st of 2000 higher than 1,458 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03051464 · 131 participants · Phase 2
No Surgery Trial / Two Dose-escalation Strategies
- NCT04301843 · 131 participants · Phase 2
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
- NCT04748549 · 131 participants · NA
Intraoperative VR for Older Patients Undergoing TKA
- NCT05951179 · 131 participants · Phase 2
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI